title: High-dose-rate interstitial brachytherapy for mucinous adenocarcinoma endocervical-type--a case study.
abstract: BACKGROUND
  Adenocarcinoma in cervical cancer has poorer response rate to treatment and requires longer time to achieve complete remission than squamous cell carcinoma [1]. Lower response to chemotherapy and radiotherapy is observed [2,3,4,5] and the optimal management remains undefined [1,4,6,7].
  
  
  METHODS
  We report a case of a 58-year-old woman with bulky mucinous adenocarcinoma endocervical-type G1, treated previously with radiochemotherapy with no visible response. After subsequent interstitial HDR brachytherapy (iHDR-BT) complete local remission was achieved.
  
  
  CONCLUSIONS
  Interstitial HDR brachytherapy in bulky mucinous adenocarcinoma endocervical-type may be the best treatment choice that allows to receive a complete local response.
authors: Brachytherapy Department, Maria Sklodowska-Curie Memorial Cancer Centre and institute of Oncology Gliwice Branch, Poland. kellass@wp.pl
authors: Sylwia
authors: S
authors: Kellas-Sleczka
authors: Brachytherapy Department, Maria Sklodowska-Curie Memorial Cancer Centre and institute of Oncology Gliwice Branch, Poland.
authors: Brygida
authors: B
authors: Białas
authors: Department of Radiotherapy and Brachytherapy Planning, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology Gliwice Branch, Poland.
authors: Marta
authors: M
authors: Szlag
authors: III Radiotherapy Clinic/Teaching Hospital, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology Gliwice Branch, Poland.
authors: Katarzyna
authors: K
authors: Raczek-Zwierzycka
authors: Brachytherapy Department, Maria Sklodowska-Curie Memorial Cancer Centre and institute of Oncology Gliwice Branch, Poland.
authors: Marek
authors: M
authors: Fijalkowski
mesh_terms: D002288:Adenocarcinoma, Mucinous / Q000532:radiotherapy*; D001918:Brachytherapy / Q000379:methods*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011879:Radiotherapy Dosage; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy*